View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 24, 2018updated 31 Jan 2022 10:37am

Hologic releases radiofrequency device to minimise wrinkles

Hologic division Cynosure has released the US Food and Drug Administration (FDA) cleared advanced Tempsure Envi radiofrequency device for aesthetic skin care.

Hologic division Cynosure has released the US Food and Drug Administration (FDA ) cleared advanced Tempsure Envi radiofrequency device for aesthetic skin care.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The device has been designed to reduce fine facial lines and wrinkles, tighten skin with soft tissue coagulation, and improve cellulite appearance.

TempSure Envi works by heating the skin’s deep layers to regenerate collagen as well as improve the appearance of cellulite and wrinkles that appear on the forehead, mouth and eyes.

Claimed to be suitable for any type of skin, treatment with the device ranges from 30 to 60 minutes, depending on the target area.

The device features the Therapeutic Logic Control (TLC) system that facilitates consistent treatment temperatures and better patient comfort levels by connecting treatment time with the target temperature.

“Treatment with the device ranges from 30 to 60 minutes, depending on the target area.”

Hologic Cynosure division president Kevin Thornal said: “With a customer base looking to diversify their specialty offerings beyond laser and injectable treatments, we are enthusiastic about the opportunity to provide a radiofrequency platform as effective and versatile as TempSure Envi.

“We also look forward to a variety of future TempSure FDA clearances, including surgical and women’s health capabilities, among others, meeting additional critical customer needs.”

Cynosure develops and manufactures various light-based aesthetic and medical treatment systems for different applications such as scar reduction, hair removal, skin revitalisation, and vascular lesions treatment.

In addition to TempSure Envi, the firm’s portfolio comprises multiple products, including Accolade , Cellulaze, Emerge , ICON , PelleFirm RF Body Treatment System, and SculpSure.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network